About this trial
Prospective double blind randomized controlled trial. By randomizing patients undergoing kidney transplantation into a conventional catecholamine drug (dobutamine) blood pressure maintenance group and a terlipressin-complexed dobutamine group, the investigators compared the effect of intraoperative blood pressure maintenance and the dosage of the vasoactive drug, postoperative graft function, delayed graft function, and other related complications between the two groups, in order to demonstrate whether the use of terlipressin for blood pressure regulation during kidney transplantation is superior to the existing treatments.
Eligibility criteria
Qualifiers
Patients with end-stage renal disease aged 18 years or above
Disqualifiers
simultaneous multiple organ transplantation
known allergy to study medication
known pregnancy status
cancellation of surgery due to grafts or personal reasons
Trial design
Treatments tested in this trial
- terlipressin
- Placebo (Normal Saline)